Federal subpoenas are latest in opioid actions.
Approval made via international collaborative effort.
Recent approval under new international Project Orbis.
FDA cites 15 companies making unsubstantiated health claims.
Hemoglobin S Polymerization inhibitor oral treatment.
PBM mergers contribute to pricing problems, ACP says.
Approved for patients 18 years of age and older
Antibiotic with a novel penetrative mechanism.
Expected U.S. launch in 2023.
First and currently only biological targeting P-selectin.